CARDIFF ONCOLOGY, INC. Prepaid Expense and Other Assets, Current
CARDIFF ONCOLOGY, INC. (CRDF) had Prepaid Expense and Other Assets, Current of $2.30 million as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2024-02-29
- 2023-12-31: Prepaid Expense and Other Assets, Current $2.30M.
- 2022-12-31: Prepaid Expense and Other Assets, Current $5.25M.
- 2021-12-31: Prepaid Expense and Other Assets, Current $4.77M.
- 2020-12-31: Prepaid Expense and Other Assets, Current $2.06M; Prepaid Expense and Other Assets, Current as first filed $2.06M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2023-12-31 | $2.30M 10-K · filed 2024-02-29 | |
| 2022-12-31 | $5.25M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $4.77M 10-K · filed 2023-03-02 | |
| 2020-12-31 | $2.06M 10-K · filed 2022-02-24 | $2.06M 10-K · filed 2021-02-25 |
| 2019-12-31 | $954.96K 10-K · filed 2021-02-25 | |
| 2018-12-31 | $1.14M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $849.08K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $1.00M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $1.07M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $1.17M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $939.20K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $713.91K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $845.85K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $956.62K 10-K · filed 2018-02-26 | |
| 2016-09-30 | $946.39K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $877.85K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $840.72K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $789.28K 10-K · filed 2017-03-15 | |
| 2015-09-30 | $600.93K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $508.41K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $418.04K 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $369.26K 10-K · filed 2016-03-10 | |
| 2014-09-30 | $348.02K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $295.75K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $262.19K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $152.79K 10-K · filed 2015-03-12 | |
| 2013-09-30 | $129.39K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $164.72K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $127.08K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $60.04K 10-K · filed 2014-03-17 | |
| 2012-09-30 | $57.25K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $29.74K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $42.44K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $42.66K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |